{"@context":{"@vocab":"https://schema.org/"},"@type":"Drug","@id":"https://api.ai-analytics.org/drug-product/63323-488#drug","name":"Xylocaine MPF","alternateName":"LIDOCAINE HYDROCHLORIDE,EPINEPHRINE BITARTRATE","identifier":[{"@type":"PropertyValue","propertyID":"FDA National Drug Code (NDC)","value":"63323-488"},{"@type":"PropertyValue","propertyID":"FDA application number","value":"NDA006488"},{"@type":"PropertyValue","propertyID":"UNII","value":"EC2CNF7XFP|30Q7KI53AK"},{"@type":"PropertyValue","propertyID":"SPL Set ID","value":"ba082c2f-64f4-419d-9c88-74f203316e17"}],"activeIngredient":"EPINEPHRINE BITARTRATE, LIDOCAINE HYDROCHLORIDE ANHYDROUS","administrationRoute":["EPIDURAL","INFILTRATION","INTRACAUDAL","PERINEURAL"],"dosageForm":"INJECTION, SOLUTION","manufacturer":{"@type":"Organization","name":"Fresenius Kabi USA, LLC"},"drugClass":[],"isAvailableGenerically":false,"legalStatus":"HUMAN PRESCRIPTION DRUG","sameAs":["https://api.ai-analytics.org/drug-approval/NDA006488","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ba082c2f-64f4-419d-9c88-74f203316e17","https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=63323-488"],"isAccessibleForFree":true,"license":"https://creativecommons.org/publicdomain/zero/1.0/","_source":{"data_provider":"AI Analytics","data_provider_url":"https://api.ai-analytics.org","license":"https://creativecommons.org/publicdomain/zero/1.0/","primary_source":"https://open.fda.gov/apis/drug/ndc/","generated_at":"2026-09-27T14:29:43.189Z"}}